English

PHARMAKINETICS LABORATORIES INC

EDGAR

Annual report amendment (10-K/A) · filed 2003-06-30

35 filing records in this dataset, filed from 1995-05-12 to 2003-06-30. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.55 million USD

2003-06-30 · USD

Exact inputs and evidence

Revenue: 6798000 USD Source
Revenue: 3244000 USD Source

Operating margin

-2.81%

2003-06-30 · %

Exact inputs and evidence

Operating Income: -1488000 USD Source
Operating Income: -1388000 USD Source
Revenue: 6798000 USD Source
Revenue: 3244000 USD Source

Operating cash flow

-48 thousand USD

2003-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -688000 USD Source
Operating Cash Flow: -640000 USD Source

Free cash flow

-275 thousand USD

2003-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -688000 USD Source
Operating Cash Flow: -640000 USD Source
Capital Expenditure: 265000 USD Source
Capital Expenditure: 38000 USD Source

Cash and cash equivalents: 46 thousand USD 2003-06-30 Source
Exact value

46000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

6.8 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Revenue: 1194000 USD · 2002-07-01 – 2002-09-30 Source
Revenue: 1084000 USD · 2002-10-01 – 2002-12-31 Source
Revenue: 966000 USD · 2003-01-01 – 2003-03-31 Source
Revenue: 6798000 USD · 2002-07-01 – 2003-06-30 Source
Revenue: 3244000 USD · 2002-07-01 – 2003-03-31 Source

Net income

-1.48 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Net income: -490000 USD · 2002-07-01 – 2002-09-30 Source
Net income: -954000 USD · 2002-07-01 – 2002-12-31 Source
Net income: -490000 USD · 2002-07-01 – 2002-09-30 Source
Net income: -1445000 USD · 2002-07-01 – 2003-03-31 Source
Net income: -954000 USD · 2002-07-01 – 2002-12-31 Source
Net income: -1483000 USD · 2002-07-01 – 2003-06-30 Source
Net income: -1445000 USD · 2002-07-01 – 2003-03-31 Source

Operating cash flow

-688 thousand USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Operating cash flow: -214000 USD · 2002-07-01 – 2002-09-30 Source
Operating cash flow: -363000 USD · 2002-07-01 – 2002-12-31 Source
Operating cash flow: -214000 USD · 2002-07-01 – 2002-09-30 Source
Operating cash flow: -640000 USD · 2002-07-01 – 2003-03-31 Source
Operating cash flow: -363000 USD · 2002-07-01 – 2002-12-31 Source
Operating cash flow: -688000 USD · 2002-07-01 – 2003-06-30 Source
Operating cash flow: -640000 USD · 2002-07-01 – 2003-03-31 Source

Capital expenditure

265 thousand USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Capital expenditure: 0 USD · 2002-07-01 – 2002-09-30 Source
Capital expenditure: 38000 USD · 2002-07-01 – 2002-12-31 Source
Capital expenditure: 0 USD · 2002-07-01 – 2002-09-30 Source
Capital expenditure: 38000 USD · 2002-07-01 – 2003-03-31 Source
Capital expenditure: 38000 USD · 2002-07-01 – 2002-12-31 Source
Capital expenditure: 265000 USD · 2002-07-01 – 2003-06-30 Source
Capital expenditure: 38000 USD · 2002-07-01 – 2003-03-31 Source

Free cash flow

-953 thousand USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Operating cash flow: -214000 USD · 2002-07-01 – 2002-09-30 Source
Operating cash flow: -363000 USD · 2002-07-01 – 2002-12-31 Source
Operating cash flow: -214000 USD · 2002-07-01 – 2002-09-30 Source
Operating cash flow: -640000 USD · 2002-07-01 – 2003-03-31 Source
Operating cash flow: -363000 USD · 2002-07-01 – 2002-12-31 Source
Operating cash flow: -688000 USD · 2002-07-01 – 2003-06-30 Source
Operating cash flow: -640000 USD · 2002-07-01 – 2003-03-31 Source
Capital expenditure: 0 USD · 2002-07-01 – 2002-09-30 Source
Capital expenditure: 38000 USD · 2002-07-01 – 2002-12-31 Source
Capital expenditure: 0 USD · 2002-07-01 – 2002-09-30 Source
Capital expenditure: 38000 USD · 2002-07-01 – 2003-03-31 Source
Capital expenditure: 38000 USD · 2002-07-01 – 2002-12-31 Source
Capital expenditure: 265000 USD · 2002-07-01 – 2003-06-30 Source
Capital expenditure: 38000 USD · 2002-07-01 – 2003-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-06-30.

Financial data available through: 2003-06-30.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2003-06-30
Operating income: 11 of 11 periods available· newest 2003-06-30
Net income: 11 of 11 periods available· newest 2003-06-30
Operating cash flow: 11 of 11 periods available· newest 2003-06-30
Capital expenditure: 5 of 11 periods available· newest 2003-06-30
Total assets: 7 of 11 periods available· newest 2000-06-30
Total liabilities: 7 of 11 periods available· newest 2000-06-30
Current assets: 10 of 11 periods available· newest 2003-06-30
Current liabilities: 10 of 11 periods available· newest 2003-06-30
Cash and cash equivalents: 10 of 11 periods available· newest 2003-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-23.7%

Prior period

USD 8.91 million

2001-07-01 – 2002-06-30
Current period

USD 6.8 million

2002-07-01 – 2003-06-30

Exact inputs and evidence

6798000 − 8913000 = -2115000 USD

8913000 USD · 2001-07-01 – 2002-06-30
Inspect prior input Prior source
6798000 USD · 2002-07-01 – 2003-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PHARMAKINETICS LABORATORIES INC · 2003-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Year-over-year change in Revenue: -2115000 USD Concept: fundies:Revenue Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 6798000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1300 Input fundies:Revenue: 8913000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1300
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 970,000

Prior period

−USD 513,000

2001-07-01 – 2002-06-30
Current period

−USD 1.48 million

2002-07-01 – 2003-06-30

Exact inputs and evidence

-1483000 − -513000 = -970000 USD

-513000 USD · 2001-07-01 – 2002-06-30
Inspect prior input Prior source
-1483000 USD · 2002-07-01 – 2003-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PHARMAKINETICS LABORATORIES INC · 2003-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Year-over-year change in Net income: -970000 USD Concept: fundies:NetIncome Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1483000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1397 Input fundies:NetIncome: -513000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1397
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-538.2%

Prior period

USD 157,000

2001-07-01 – 2002-06-30
Current period

−USD 688,000

2002-07-01 – 2003-06-30

Exact inputs and evidence

-688000 − 157000 = -845000 USD

157000 USD · 2001-07-01 – 2002-06-30
Inspect prior input Prior source
-688000 USD · 2002-07-01 – 2003-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PHARMAKINETICS LABORATORIES INC · 2003-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Year-over-year change in Operating cash flow: -845000 USD Concept: fundies:OperatingCashFlow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -688000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1415 Input fundies:OperatingCashFlow: 157000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1415
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+846.4%

Prior period

USD 28,000

2001-07-01 – 2002-06-30
Current period

USD 265,000

2002-07-01 – 2003-06-30

Exact inputs and evidence

265000 − 28000 = 237000 USD

28000 USD · 2001-07-01 – 2002-06-30
Inspect prior input Prior source
265000 USD · 2002-07-01 – 2003-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PHARMAKINETICS LABORATORIES INC · 2003-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Year-over-year change in Capital expenditure: 237000 USD Concept: fundies:CapitalExpenditure Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 265000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1418 Input fundies:CapitalExpenditure: 28000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1418
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2003 2002-07-01 – 2003-06-30

Revenue USD 6.8 million 100% of revenue
Operating costs Derived USD 8.29 million 122% of revenue
Operating income −USD 1.49 million −22% of revenue
Tax, interest and other Derived −USD 5,000 −0.1% of revenue
Net income −USD 1.48 million −22% of revenue

Cash

Operating cash flow −USD 688,000 −10% of revenue
Capital expenditure USD 265,000 3.9% of revenue
Free cash flow Derived −USD 953,000 −14% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 95%
1995 95%
1996 91%
1997 Net loss: net income was −1.1% of revenue.
1998 Net income was higher than operating income, so the split is not drawn.
1999 Operating loss: operating costs were 114% of revenue.
2000 Operating loss: operating costs were 139% of revenue.
2001 Operating loss: operating costs were 139% of revenue.
2002 Operating loss: operating costs were 106% of revenue.
2003 Operating loss: operating costs were 122% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1993-07-01 – 1994-06-30	8847674	8437234 Derived	410440	205589 Derived	204851	Unavailable	Source 1993-07-01 – 1994-06-30: 8847674 USD Inspect Revenue Open source 1993-07-01 – 1994-06-30: 410440 USD Inspect Operating Income Open source 1993-07-01 – 1994-06-30: 204851 USD Inspect Net Income Open source 1993-07-01 – 1994-06-30: 316154 USD Inspect Operating Cash Flow Open source
1995 1994-07-01 – 1995-06-30	9893762	9432990 Derived	460772	332945 Derived	127827	Unavailable	Source 1994-07-01 – 1995-06-30: 9893762 USD Inspect Revenue Open source 1994-07-01 – 1995-06-30: 460772 USD Inspect Operating Income Open source 1994-07-01 – 1995-06-30: 127827 USD Inspect Net Income Open source 1994-07-01 – 1995-06-30: 634525 USD Inspect Operating Cash Flow Open source
1996 1995-07-01 – 1996-06-30	10962160	9976707 Derived	985453	206558 Derived	778895	Unavailable	Source 1995-07-01 – 1996-06-30: 10962160 USD Inspect Revenue Open source 1995-07-01 – 1996-06-30: 985453 USD Inspect Operating Income Open source 1995-07-01 – 1996-06-30: 778895 USD Inspect Net Income Open source 1995-07-01 – 1996-06-30: 528090 USD Inspect Operating Cash Flow Open source
1997 1996-07-01 – 1997-06-30	9597536	9557449 Derived	40087	149600 Derived	-109513	Unavailable	Source 1996-07-01 – 1997-06-30: 9597536 USD Inspect Revenue Open source 1996-07-01 – 1997-06-30: 40087 USD Inspect Operating Income Open source 1996-07-01 – 1997-06-30: -109513 USD Inspect Net Income Open source 1996-07-01 – 1997-06-30: -7864 USD Inspect Operating Cash Flow Open source
1998 1997-07-01 – 1998-06-30	12326009	11709262 Derived	616747	-6000 Derived	622747	Unavailable	Source 1997-07-01 – 1998-06-30: 12326009 USD Inspect Revenue Open source 1997-07-01 – 1998-06-30: 616747 USD Inspect Operating Income Open source 1997-07-01 – 1998-06-30: 622747 USD Inspect Net Income Open source 1997-07-01 – 1998-06-30: 207370 USD Inspect Operating Cash Flow Open source
1999 1998-07-01 – 1999-06-30	9828369	11192808 Derived	-1364439	-36724 Derived	-1327715	-1088873 Derived	Source 1998-07-01 – 1999-06-30: 9828369 USD Inspect Revenue Open source 1998-07-01 – 1999-06-30: -1364439 USD Inspect Operating Income Open source 1998-07-01 – 1999-06-30: -1327715 USD Inspect Net Income Open source 1998-07-01 – 1999-06-30: 18932 USD Inspect Operating Cash Flow Open source 1998-07-01 – 1999-06-30: 1107805 USD Inspect Capital Expenditure Open source
2000 1999-07-01 – 2000-06-30	8024000	11134000 Derived	-3110000	-152000 Derived	-2958000	-1972000 Derived	Source 1999-07-01 – 2000-06-30: 8024000 USD Inspect Revenue Open source 1999-07-01 – 2000-06-30: -3110000 USD Inspect Operating Income Open source 1999-07-01 – 2000-06-30: -2958000 USD Inspect Net Income Open source 1999-07-01 – 2000-06-30: -1617000 USD Inspect Operating Cash Flow Open source 1999-07-01 – 2000-06-30: 355000 USD Inspect Capital Expenditure Open source
2001 2000-07-01 – 2001-06-30	8024000	11134000 Derived	-3110000	-152000 Derived	-2958000	-1972000 Derived	Source 2000-07-01 – 2001-06-30: 8024000 USD Inspect Revenue Open source 2000-07-01 – 2001-06-30: -3110000 USD Inspect Operating Income Open source 2000-07-01 – 2001-06-30: -2958000 USD Inspect Net Income Open source 2000-07-01 – 2001-06-30: -1617000 USD Inspect Operating Cash Flow Open source 2000-07-01 – 2001-06-30: 355000 USD Inspect Capital Expenditure Open source
2002 2001-07-01 – 2002-06-30	8913000	9462000 Derived	-549000	-36000 Derived	-513000	129000 Derived	Source 2001-07-01 – 2002-06-30: 8913000 USD Inspect Revenue Open source 2001-07-01 – 2002-06-30: -549000 USD Inspect Operating Income Open source 2001-07-01 – 2002-06-30: -513000 USD Inspect Net Income Open source 2001-07-01 – 2002-06-30: 157000 USD Inspect Operating Cash Flow Open source 2001-07-01 – 2002-06-30: 28000 USD Inspect Capital Expenditure Open source
2003 2002-07-01 – 2003-06-30	6798000	8286000 Derived	-1488000	-5000 Derived	-1483000	-953000 Derived	Source 2002-07-01 – 2003-06-30: 6798000 USD Inspect Revenue Open source 2002-07-01 – 2003-06-30: -1488000 USD Inspect Operating Income Open source 2002-07-01 – 2003-06-30: -1483000 USD Inspect Net Income Open source 2002-07-01 – 2003-06-30: -688000 USD Inspect Operating Cash Flow Open source 2002-07-01 – 2003-06-30: 265000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.8M 2003

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-06-30	Revenue	8847674	Revenue: 8847674 Open source
19951995-06-30	Revenue	9893762	Revenue: 9893762 Open source
19961996-06-30	Revenue	10962160	Revenue: 10962160 Open source
19971997-06-30	Revenue	9597536	Revenue: 9597536 Open source
19981998-06-30	Revenue	12326009	Revenue: 12326009 Open source
19991999-06-30	Revenue	9828369	Revenue: 9828369 Open source
20002000-06-30	Revenue	8024000	Revenue: 8024000 Open source
20012001-06-30	Revenue	8024000	Revenue: 8024000 Open source
20022002-06-30	Revenue	8913000	Revenue: 8913000 Open source
20032003-06-30	Revenue	6798000	Revenue: 6798000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-23.7% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-06-30	Year over year	No prior comparable period	Revenue: 8847674 Open source
19951995-06-30	Year over year	11.8%	Revenue: 9893762 Open source Revenue: 8847674 Open source
19961996-06-30	Year over year	10.8%	Revenue: 10962160 Open source Revenue: 9893762 Open source
19971997-06-30	Year over year	-12.4%	Revenue: 9597536 Open source Revenue: 10962160 Open source
19981998-06-30	Year over year	28.4%	Revenue: 12326009 Open source Revenue: 9597536 Open source
19991999-06-30	Year over year	-20.3%	Revenue: 9828369 Open source Revenue: 12326009 Open source
20002000-06-30	Year over year	-18.4%	Revenue: 8024000 Open source Revenue: 9828369 Open source
20012001-06-30	Year over year	0%	Revenue: 8024000 Open source Revenue: 8024000 Open source
20022002-06-30	Year over year	11.1%	Revenue: 8913000 Open source Revenue: 8024000 Open source
20032003-06-30	Year over year	-23.7%	Revenue: 6798000 Open source Revenue: 8913000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -21.9% 2003

Net margin -21.8% 2003

Free cash flow margin -14% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-06-30	Operating margin	4.6%	Operating Income: 410440 Open source Revenue: 8847674 Open source
19951995-06-30	Operating margin	4.7%	Operating Income: 460772 Open source Revenue: 9893762 Open source
19961996-06-30	Operating margin	9%	Operating Income: 985453 Open source Revenue: 10962160 Open source
19971997-06-30	Operating margin	0.4%	Operating Income: 40087 Open source Revenue: 9597536 Open source
19981998-06-30	Operating margin	5%	Operating Income: 616747 Open source Revenue: 12326009 Open source
19991999-06-30	Operating margin	-13.9%	Operating Income: -1364439 Open source Revenue: 9828369 Open source
20002000-06-30	Operating margin	-38.8%	Operating Income: -3110000 Open source Revenue: 8024000 Open source
20012001-06-30	Operating margin	-38.8%	Operating Income: -3110000 Open source Revenue: 8024000 Open source
20022002-06-30	Operating margin	-6.2%	Operating Income: -549000 Open source Revenue: 8913000 Open source
20032003-06-30	Operating margin	-21.9%	Operating Income: -1488000 Open source Revenue: 6798000 Open source
19941994-06-30	Net margin	2.3%	Net Income: 204851 Open source Revenue: 8847674 Open source
19951995-06-30	Net margin	1.3%	Net Income: 127827 Open source Revenue: 9893762 Open source
19961996-06-30	Net margin	7.1%	Net Income: 778895 Open source Revenue: 10962160 Open source
19971997-06-30	Net margin	-1.1%	Net Income: -109513 Open source Revenue: 9597536 Open source
19981998-06-30	Net margin	5.1%	Net Income: 622747 Open source Revenue: 12326009 Open source
19991999-06-30	Net margin	-13.5%	Net Income: -1327715 Open source Revenue: 9828369 Open source
20002000-06-30	Net margin	-36.9%	Net Income: -2958000 Open source Revenue: 8024000 Open source
20012001-06-30	Net margin	-36.9%	Net Income: -2958000 Open source Revenue: 8024000 Open source
20022002-06-30	Net margin	-5.8%	Net Income: -513000 Open source Revenue: 8913000 Open source
20032003-06-30	Net margin	-21.8%	Net Income: -1483000 Open source Revenue: 6798000 Open source
19941994-06-30	Free cash flow margin	Not reported	Revenue: 8847674 Open source Operating Cash Flow: 316154 Open source
19951995-06-30	Free cash flow margin	Not reported	Revenue: 9893762 Open source Operating Cash Flow: 634525 Open source
19961996-06-30	Free cash flow margin	Not reported	Revenue: 10962160 Open source Operating Cash Flow: 528090 Open source
19971997-06-30	Free cash flow margin	Not reported	Revenue: 9597536 Open source Operating Cash Flow: -7864 Open source
19981998-06-30	Free cash flow margin	Not reported	Revenue: 12326009 Open source Operating Cash Flow: 207370 Open source
19991999-06-30	Free cash flow margin	-11.1%	Revenue: 9828369 Open source Operating Cash Flow: 18932 Open source Capital Expenditure: 1107805 Open source
20002000-06-30	Free cash flow margin	-24.6%	Revenue: 8024000 Open source Operating Cash Flow: -1617000 Open source Capital Expenditure: 355000 Open source
20012001-06-30	Free cash flow margin	-24.6%	Revenue: 8024000 Open source Operating Cash Flow: -1617000 Open source Capital Expenditure: 355000 Open source
20022002-06-30	Free cash flow margin	1.4%	Revenue: 8913000 Open source Operating Cash Flow: 157000 Open source Capital Expenditure: 28000 Open source
20032003-06-30	Free cash flow margin	-14%	Revenue: 6798000 Open source Operating Cash Flow: -688000 Open source Capital Expenditure: 265000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -688K 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-06-30	Operating cash flow	316154	Operating Cash Flow: 316154 Open source
19951995-06-30	Operating cash flow	634525	Operating Cash Flow: 634525 Open source
19961996-06-30	Operating cash flow	528090	Operating Cash Flow: 528090 Open source
19971997-06-30	Operating cash flow	-7864	Operating Cash Flow: -7864 Open source
19981998-06-30	Operating cash flow	207370	Operating Cash Flow: 207370 Open source
19991999-06-30	Operating cash flow	18932	Operating Cash Flow: 18932 Open source
20002000-06-30	Operating cash flow	-1617000	Operating Cash Flow: -1617000 Open source
20012001-06-30	Operating cash flow	-1617000	Operating Cash Flow: -1617000 Open source
20022002-06-30	Operating cash flow	157000	Operating Cash Flow: 157000 Open source
20032003-06-30	Operating cash flow	-688000	Operating Cash Flow: -688000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -953K 2003

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-06-30	Free cash flow	Unavailable	Operating Cash Flow: 316154 Open source
19951995-06-30	Free cash flow	Unavailable	Operating Cash Flow: 634525 Open source
19961996-06-30	Free cash flow	Unavailable	Operating Cash Flow: 528090 Open source
19971997-06-30	Free cash flow	Unavailable	Operating Cash Flow: -7864 Open source
19981998-06-30	Free cash flow	Unavailable	Operating Cash Flow: 207370 Open source
19991999-06-30	Free cash flow	-1088873	Operating Cash Flow: 18932 Open source Capital Expenditure: 1107805 Open source
20002000-06-30	Free cash flow	-1972000	Operating Cash Flow: -1617000 Open source Capital Expenditure: 355000 Open source
20012001-06-30	Free cash flow	-1972000	Operating Cash Flow: -1617000 Open source Capital Expenditure: 355000 Open source
20022002-06-30	Free cash flow	129000	Operating Cash Flow: 157000 Open source Capital Expenditure: 28000 Open source
20032003-06-30	Free cash flow	-953000	Operating Cash Flow: -688000 Open source Capital Expenditure: 265000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

40.4% 2000

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19941994-06-30	Liabilities / assets	75%	Total Liabilities: 4622459 Open source Total Assets: 6163128 Open source
19951995-06-30	Liabilities / assets	73%	Total Liabilities: 4784489 Open source Total Assets: 6553348 Open source
19961996-06-30	Liabilities / assets	61.5%	Total Liabilities: 4075205 Open source Total Assets: 6622959 Open source
19971997-06-30	Liabilities / assets	59.1%	Total Liabilities: 3520491 Open source Total Assets: 5958732 Open source
19981998-06-30	Liabilities / assets	22.1%	Total Liabilities: 2233895 Open source Total Assets: 10107478 Open source
19991999-06-30	Liabilities / assets	29.1%	Total Liabilities: 2697711 Open source Total Assets: 9284954 Open source
20002000-06-30	Liabilities / assets	40.4%	Total Liabilities: 2647559 Open source Total Assets: 6550186 Open source
2001-06-30	Liabilities / assets	Not reported	No source recorded
2002-06-30	Liabilities / assets	Not reported	No source recorded
2003-06-30	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

0.42× 2003

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19941994-06-30	Current assets / current liabilities	1.12×	Current Assets: 2447718 Open source Current Liabilities: 2185086 Open source
19951995-06-30	Current assets / current liabilities	0.98×	Current Assets: 2646906 Open source Current Liabilities: 2710380 Open source
19961996-06-30	Current assets / current liabilities	1.18×	Current Assets: 2701827 Open source Current Liabilities: 2290329 Open source
19971997-06-30	Current assets / current liabilities	1.14×	Current Assets: 2264084 Open source Current Liabilities: 1981546 Open source
19981998-06-30	Current assets / current liabilities	3.04×	Current Assets: 6081466 Open source Current Liabilities: 1998821 Open source
19991999-06-30	Current assets / current liabilities	1.9×	Current Assets: 4842465 Open source Current Liabilities: 2555009 Open source
20002000-06-30	Current assets / current liabilities	0.95×	Current Assets: 2468858 Open source Current Liabilities: 2585508 Open source
20012001-06-30	Current assets / current liabilities	0.95×	Current Assets: 2191000 Open source Current Liabilities: 2313000 Open source
20022002-06-30	Current assets / current liabilities	0.42×	Current Assets: 915000 Open source Current Liabilities: 2173000 Open source
20032003-06-30	Current assets / current liabilities	0.42×	Current Assets: 915000 Open source Current Liabilities: 2173000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1993-07-01 – 1994-06-30	USD 204,851 Exact value Exact value: 204851 USD 1993-07-01 – 1994-06-30: 204851 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 1994-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: 204851 USD Concept: fundies:NetIncome Period: 1993-07-01 to 1994-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=1994-06-30&surface=latest&period_type=duration&start=1993-07-01&unit=USD&dimensions= Input fundies:NetIncome: 204851 USD (1993-07-01 to 1994-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000351506-96-000006.txt#1273 The citation records this snapshot. The page link may show a newer release later.	USD 316,154 Exact value Exact value: 316154 USD 1993-07-01 – 1994-06-30: 316154 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 1994-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: 316154 USD Concept: fundies:OperatingCashFlow Period: 1993-07-01 to 1994-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=1994-06-30&surface=latest&period_type=duration&start=1993-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 316154 USD (1993-07-01 to 1994-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000351506-96-000006.txt#1292 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1995 1994-07-01 – 1995-06-30	USD 127,827 Exact value Exact value: 127827 USD 1994-07-01 – 1995-06-30: 127827 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 1995-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: 127827 USD Concept: fundies:NetIncome Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=1995-06-30&surface=latest&period_type=duration&start=1994-07-01&unit=USD&dimensions= Input fundies:NetIncome: 127827 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000351506-97-000010.txt#1164 The citation records this snapshot. The page link may show a newer release later.	USD 634,525 Exact value Exact value: 634525 USD 1994-07-01 – 1995-06-30: 634525 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 1995-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: 634525 USD Concept: fundies:OperatingCashFlow Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=1995-06-30&surface=latest&period_type=duration&start=1994-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 634525 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000351506-97-000010.txt#1184 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1996 1995-07-01 – 1996-06-30	USD 778,895 Exact value Exact value: 778895 USD 1995-07-01 – 1996-06-30: 778895 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 1996-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: 778895 USD Concept: fundies:NetIncome Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=1996-06-30&surface=latest&period_type=duration&start=1995-07-01&unit=USD&dimensions= Input fundies:NetIncome: 778895 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000351506-98-000013.txt#1577 The citation records this snapshot. The page link may show a newer release later.	USD 528,090 Exact value Exact value: 528090 USD 1995-07-01 – 1996-06-30: 528090 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 1996-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: 528090 USD Concept: fundies:OperatingCashFlow Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=1996-06-30&surface=latest&period_type=duration&start=1995-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 528090 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000351506-98-000013.txt#1592 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1996-07-01 – 1997-06-30	−USD 109,513 Exact value Exact value: -109513 USD 1996-07-01 – 1997-06-30: -109513 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 1997-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: -109513 USD Concept: fundies:NetIncome Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:NetIncome: -109513 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000950168-99-002527.txt#1538 The citation records this snapshot. The page link may show a newer release later.	−USD 7,864 Exact value Exact value: -7864 USD 1996-07-01 – 1997-06-30: -7864 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 1997-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: -7864 USD Concept: fundies:OperatingCashFlow Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7864 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000950168-99-002527.txt#1552 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1997-07-01 – 1998-06-30	USD 622,747 Exact value Exact value: 622747 USD 1997-07-01 – 1998-06-30: 622747 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 1998-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: 622747 USD Concept: fundies:NetIncome Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:NetIncome: 622747 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000950169-00-001212.txt#1515 The citation records this snapshot. The page link may show a newer release later.	USD 207,370 Exact value Exact value: 207370 USD 1997-07-01 – 1998-06-30: 207370 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 1998-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: 207370 USD Concept: fundies:OperatingCashFlow Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 207370 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0000950169-00-001212.txt#1532 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1998-07-01 – 1999-06-30	−USD 1.33 million Exact value Exact value: -1327715 USD 1998-07-01 – 1999-06-30: -1327715 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 1999-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: -1327715 USD Concept: fundies:NetIncome Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:NetIncome: -1327715 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001021408-01-507483.txt#1311 The citation records this snapshot. The page link may show a newer release later.	USD 18,932 Exact value Exact value: 18932 USD 1998-07-01 – 1999-06-30: 18932 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 1999-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: 18932 USD Concept: fundies:OperatingCashFlow Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 18932 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001021408-01-507483.txt#1327 The citation records this snapshot. The page link may show a newer release later.	USD 1.11 million Exact value Exact value: 1107805 USD 1998-07-01 – 1999-06-30: 1107805 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAKINETICS LABORATORIES INC · 1999-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Capital Expenditure: 1107805 USD Concept: fundies:CapitalExpenditure Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ACapitalExpenditure&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1107805 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001021408-01-507483.txt#1331 The citation records this snapshot. The page link may show a newer release later.	−USD 1.09 million Calculation and evidence 18932 − 1107805 USD Exact free cash flow: -1088873 USD 1998-07-01 – 1999-06-30: 18932 USD · Inspect Operating Cash Flow · Source 1998-07-01 – 1999-06-30: 1107805 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAKINETICS LABORATORIES INC · 1999-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Free cash flow: -1088873 USD Concept: free-cash-flow Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 18932 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001021408-01-507483.txt#1327 Input fundies:CapitalExpenditure: 1107805 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001021408-01-507483.txt#1331 The citation records this snapshot. The page link may show a newer release later.
2000 1999-07-01 – 2000-06-30	−USD 2.96 million Exact value Exact value: -2958000 USD 1999-07-01 – 2000-06-30: -2958000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 2000-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: -2958000 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:NetIncome: -2958000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001145236-02-000101.txt#2161 The citation records this snapshot. The page link may show a newer release later.	−USD 1.62 million Exact value Exact value: -1617000 USD 1999-07-01 – 2000-06-30: -1617000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 2000-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: -1617000 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1617000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001145236-02-000101.txt#2273 The citation records this snapshot. The page link may show a newer release later.	USD 355,000 Exact value Exact value: 355000 USD 1999-07-01 – 2000-06-30: 355000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAKINETICS LABORATORIES INC · 2000-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Capital Expenditure: 355000 USD Concept: fundies:CapitalExpenditure Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ACapitalExpenditure&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 355000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001145236-02-000101.txt#2297 The citation records this snapshot. The page link may show a newer release later.	−USD 1.97 million Calculation and evidence -1617000 − 355000 USD Exact free cash flow: -1972000 USD 1999-07-01 – 2000-06-30: -1617000 USD · Inspect Operating Cash Flow · Source 1999-07-01 – 2000-06-30: 355000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAKINETICS LABORATORIES INC · 2000-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Free cash flow: -1972000 USD Concept: free-cash-flow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1617000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001145236-02-000101.txt#2273 Input fundies:CapitalExpenditure: 355000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001145236-02-000101.txt#2297 The citation records this snapshot. The page link may show a newer release later.
2001 2000-07-01 – 2001-06-30	−USD 2.96 million Exact value Exact value: -2958000 USD 2000-07-01 – 2001-06-30: -2958000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 2001-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: -2958000 USD Concept: fundies:NetIncome Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:NetIncome: -2958000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1397 The citation records this snapshot. The page link may show a newer release later.	−USD 1.62 million Exact value Exact value: -1617000 USD 2000-07-01 – 2001-06-30: -1617000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 2001-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: -1617000 USD Concept: fundies:OperatingCashFlow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1617000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1415 The citation records this snapshot. The page link may show a newer release later.	USD 355,000 Exact value Exact value: 355000 USD 2000-07-01 – 2001-06-30: 355000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAKINETICS LABORATORIES INC · 2001-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Capital Expenditure: 355000 USD Concept: fundies:CapitalExpenditure Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ACapitalExpenditure&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 355000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1418 The citation records this snapshot. The page link may show a newer release later.	−USD 1.97 million Calculation and evidence -1617000 − 355000 USD Exact free cash flow: -1972000 USD 2000-07-01 – 2001-06-30: -1617000 USD · Inspect Operating Cash Flow · Source 2000-07-01 – 2001-06-30: 355000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAKINETICS LABORATORIES INC · 2001-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Free cash flow: -1972000 USD Concept: free-cash-flow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1617000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1415 Input fundies:CapitalExpenditure: 355000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1418 The citation records this snapshot. The page link may show a newer release later.
2002 2001-07-01 – 2002-06-30	−USD 513,000 Exact value Exact value: -513000 USD 2001-07-01 – 2002-06-30: -513000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 2002-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: -513000 USD Concept: fundies:NetIncome Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:NetIncome: -513000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1397 The citation records this snapshot. The page link may show a newer release later.	USD 157,000 Exact value Exact value: 157000 USD 2001-07-01 – 2002-06-30: 157000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 2002-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: 157000 USD Concept: fundies:OperatingCashFlow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 157000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1415 The citation records this snapshot. The page link may show a newer release later.	USD 28,000 Exact value Exact value: 28000 USD 2001-07-01 – 2002-06-30: 28000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAKINETICS LABORATORIES INC · 2002-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Capital Expenditure: 28000 USD Concept: fundies:CapitalExpenditure Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ACapitalExpenditure&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1418 The citation records this snapshot. The page link may show a newer release later.	USD 129,000 Calculation and evidence 157000 − 28000 USD Exact free cash flow: 129000 USD 2001-07-01 – 2002-06-30: 157000 USD · Inspect Operating Cash Flow · Source 2001-07-01 – 2002-06-30: 28000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAKINETICS LABORATORIES INC · 2002-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Free cash flow: 129000 USD Concept: free-cash-flow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 157000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1415 Input fundies:CapitalExpenditure: 28000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1418 The citation records this snapshot. The page link may show a newer release later.
2003 2002-07-01 – 2003-06-30	−USD 1.48 million Exact value Exact value: -1483000 USD 2002-07-01 – 2003-06-30: -1483000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAKINETICS LABORATORIES INC · 2003-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Net Income: -1483000 USD Concept: fundies:NetIncome Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ANetIncome&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:NetIncome: -1483000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1397 The citation records this snapshot. The page link may show a newer release later.	−USD 688,000 Exact value Exact value: -688000 USD 2002-07-01 – 2003-06-30: -688000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAKINETICS LABORATORIES INC · 2003-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Operating Cash Flow: -688000 USD Concept: fundies:OperatingCashFlow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3AOperatingCashFlow&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -688000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1415 The citation records this snapshot. The page link may show a newer release later.	USD 265,000 Exact value Exact value: 265000 USD 2002-07-01 – 2003-06-30: 265000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAKINETICS LABORATORIES INC · 2003-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Capital Expenditure: 265000 USD Concept: fundies:CapitalExpenditure Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506/explain?concept=fundies%3ACapitalExpenditure&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 265000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1418 The citation records this snapshot. The page link may show a newer release later.	−USD 953,000 Calculation and evidence -688000 − 265000 USD Exact free cash flow: -953000 USD 2002-07-01 – 2003-06-30: -688000 USD · Inspect Operating Cash Flow · Source 2002-07-01 – 2003-06-30: 265000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAKINETICS LABORATORIES INC · 2003-06-30 PHARMAKINETICS LABORATORIES INC (edgar:351506) Free cash flow: -953000 USD Concept: free-cash-flow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T19:46:45Z Snapshot: e5a12cf939ea912537a59d1d2f491702bf1de10be537aee05000588ed162052a Dimensions: Consolidated View: https://fundies.io/companies/edgar/351506?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -688000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1415 Input fundies:CapitalExpenditure: 265000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/351506/0001206774-03-000528.txt#1418 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

35 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000351506, 351506, edgar:351506

PHARMAKINETICS LABORATORIES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2003 2002-07-01 – 2003-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation